LONDON — Canadian-headquartered communications group Avenir Global has appointed Miranda Dini to the new role of global healthcare lead to strengthen its leadership in the sector.

Dini will continue as managing partner of Axon Communications, one of Avenir’s healthcare agencies in London, which she has led as managing partner for the past decade.

Her expanded role will involve spearheading cross-firm initiatives to further strengthen the global healthcare business across all Avenir’s agency brands, which include Hanover, Cherry, Madano, National, Padilla and Shift.

Healthcare now represents around 30% of the firm’s business across its agencies, covering insights, strategic planning, public relations, medical communications, clinical trial services, creative, branding and market access.

Avenir Global international managing partner Ralph Sutton said: “Miranda has a deep understanding of the expertise within our firm and a proven track record for driving growth and collaboration.  She is the ideal person to help orchestrate our network resources to deliver great results for our clients.”

Dini added: “What I love about our firm is that we consciously collaborate, as we know we bring different strengths and expertise to the table. By putting our clients first, we don’t get caught up in bureaucracy or agency politics.”

Avenir, which bought UK agencies Hanover in April last year and Cherry in November 2019, now has more than 1,000 employees across Europe, the Middle East, the US and Canada.